MLP Sağlık Fully Acquires Its Stake in Samsun Medikal
According to Kuveyt Türk's analyst evaluation, the target price for MLP Sağlık shares was set at 604 TL while the 'buy' recommendation was maintained.
MLP Sağlık carried out a strategic acquisition to increase its shareholding rate in Samsun Medikal Grup Özel Sağlık Hizmetleri A.Ş. to 100 percent.
Acquisition Process and Share Ratios
MLP Sağlık took over all of the 20 percent shares in the capital of Samsun Medikal Grup Özel Sağlık Hizmetleri A.Ş. This transfer transaction was implemented through Sotte Sağlık and MS Sağlık, which are 100 percent subsidiaries.
Transaction Value and Financial Details
The share transfer in Samsun Medikal, which houses 7 hospitals, was carried out at a price of 115 million dollars, or approximately 5.6 billion TL, based on the official valuation report. As a result of this transaction, MS Sağlık became a 12 percent shareholder and Sotte Sağlık became an 8 percent shareholder in the company.
Financial Ratios and Target Price
In the report shared by Kuveyt Türk, it was stated that the aforementioned agreement amount corresponds to approximately 10 percent of the company's 2025 revenue. While the company is in a net debt position of 13.25 billion TL in the current period, analysts maintained the 604 TL target price and 'buy' recommendation for MLP Sağlık shares.